BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2000
View Archived Issues
Combined vasodilating and beta-blocking properties of new NO donor PF-9404C
Read More
Oxford BioMedica and IDM to collaborate on cell-based therapies
Read More
Millennium continues to "move downstream" during Q4 and year-end 1999
Read More
Immunex highlights year-end 1999 progress
Read More
NYU School of Medicine and P&U establish anticancer drug discovery collaboration
Read More
FDA approves more than 140 new drugs and devices in 1999
Read More
Progenics receives payment from BMS for cancer vaccine collaboration
Read More
Access to begin phase II trial of OraRinse for treatment and prevention of mucositis
Read More
Insmed receives funding for clinical programs
Read More
Amine compounds as 5-HT reuptake inhibitors emerge from Lilly R&D
Read More
Potent, subtype-selective NMDA antagonists jointly developed at CoCensys & Warner-Lambert
Read More
Synthetic thyromimetics useful for hyperthyroidism, cardiac arrhythmias
Read More
ADIR's new MMP and TNF-alpha production inhibitors described in recent patent
Read More
Another series of substituted carbapenems from Merck useful against resistant pathogens
Read More
CRF antagonists with pyrazolo[1,5-a]triazine structure in development at DuPont
Read More
IC-351 improves erectile response to visual stimulation in men with mild to moderate ED
Read More
RCT patents GH treatment regimen for rheumatoid arthritis
Read More
Bayer presents new candidate treatment for ED at ESIR
Read More
Application of Ariad's Dimerizer Drug technology covered by two U.S. patents
Read More
Biomira reports survival data for therapeutic cancer vaccine
Read More
Boehringer Ingelheim adds structurally novel HIV protease inhibitor to R&D portfolio
Read More
OPC-41061 + furosemide: additive diuretic effect + beneficial effect on electrolytes
Read More
Immtech dication compounds show potential as small-molecule regulators of gene function
Read More
Servier compound S-18327 displays distinctive and promising profile as schizophrenia Rx
Read More
ML Laboratories updates AIDS products
Read More
Combined ACE inhibition and AT1 blockade does not improve coronary hemodynamics in post-MI rats
Read More
